Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products

Journal of Cardiovascular Translational Research

Volumn 4, Issue 6, 2011, Pages 790-800

  Haas, Benjamin ^a   Leonard, Frederique ^a   Ernens, Isabelle ^a   Rodius, Sophie ^a   Vausort, Melanie ^a   Rolland Turner, Magali ^a   Devaux, Yvan ^a   Wagner, Daniel R ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b Centre Hospitalier   (Luxembourg)

Author keywords

Adenosine; Inflammation; Left ventricular remodeling; Myocardial infarction; Toll like receptor 4

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; C REACTIVE PROTEIN; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION; HEART INFARCTION; HUMAN; HUMAN CELL; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; ADULT; AGED; CASE-CONTROL STUDIES; CELL MEMBRANE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HEPARITIN SULFATE; HUMANS; HYALURONIC ACID; INFLAMMATION; LIGANDS; LIPOPOLYSACCHARIDES; LUXEMBOURG; MACROPHAGES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; REGISTRIES; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81855194112     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-011-9279-x     Document Type: Article

References (28)

1. S Frantz L Kobzik YD Kim R Fukazawa R Medzhitov RT Lee, et al. 1999 Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium Journal of Clinical Investigation 104 271 280 10430608 10.1172/JCI6709 1:CAS:528:DyaK1MXkvFagtr4%3D
2. L Timmers JP Sluijter JK van Keulen IE Hoefer MG Nederhoff MJ Goumans, et al. 2008 Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction Circulation Research 102 257 264 18007026 10.1161/CIRCRESAHA.107.158220 1:CAS:528: DC%2BD1cXhtVGkur8%3D (Pubitemid 351674064)
3. H Kanzler FJ Barrat EM Hessel RL Coffman 2007 Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Natural Medicines 13 552 559 10.1038/nm1589 1:CAS:528:DC%2BD2sXkvVOgsrs%3D (Pubitemid 46830615)
4. RM Berne 1963 Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow The American Journal of Physiology 204 317 322 13971060 1:CAS:528:DyaF3sXktFWjurg%3D
5. I Ernens F Leonard M Vausort M Rolland-Turner Y Devaux DR Wagner 2010 Adenosine up-regulates vascular endothelial growth factor in human macrophages Biochemical and Biophysical Research Communications 392 351 356 10.1016/j.bbrc.2010.01.023 20067761 10.1016/j.bbrc.2010.01.023 1:CAS:528:DC%2BC3cXitVGqurs%3D
6. I Ernens D Rouy E Velot Y Devaux DR Wagner 2006 Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway Circulation Research 99 590 597 16917093 10.1161/01.RES.0000241428.82502.d4 1:CAS:528:DC%2BD28XptFClsbc%3D (Pubitemid 44401450)
7. E Velot B Haas F Leonard I Ernens M Rolland-Turner C Schwartz, et al. 2008 Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages Cardiovascular Research 80 246 254 18653544 10.1093/cvr/cvn201 1:CAS:528:DC%2BD1cXht1Knt7vF
8. M Satoh Y Shimoda C Maesawa T Akatsu Y Ishikawa Y Minami, et al. 2006 Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction International Journal of Cardiology 109 226 234 16051384 10.1016/j.ijcard.2005.06.023
9. J Oyama C Blais Jr X Liu M Pu L Kobzik RA Kelly, et al. 2004 Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice Circulation 109 784 789 14970116 10.1161/01.CIR.0000112575.66565.84 1:CAS:528:DC%2BD2cXhtFWltbw%3D (Pubitemid 38222900)
10. A Shimamoto AJ Chong M Yada S Shomura H Takayama AJ Fleisig, et al. 2006 Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury Circulation 114 I270 I274 16820585 10.1161/CIRCULATIONAHA.105.000901 (Pubitemid 44297162)
11. GM Barton JC Kagan 2009 A cell biological view of Toll-like receptor function: regulation through compartmentalization Nature Reviews. Immunology 9 535 542 10.1038/nri2587 19556980 10.1038/nri2587 1:CAS:528:DC%2BD1MXnslKqtrs%3D
12. H Husebye O Halaas H Stenmark G Tunheim O Sandanger B Bogen, et al. 2006 Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity The EMBO Journal 25 683 692 10.1038/sj.emboj.7600991 16467847 10.1038/sj.emboj.7600991 1:CAS:528:DC%2BD28Xhs1ertr8%3D (Pubitemid 43292431)
13. L Macedo G Pinhal-Enfield V Alshits G Elson BN Cronstein SJ Leibovich 2007 Wound healing is impaired in MyD88-deficient mice. A role for MyD88 in the regulation of wound healing by adenosine A2A receptors The American Journal of Pathology 171 1774 1788 17974599 10.2353/ajpath.2007.061048 1:CAS:528: DC%2BD1cXntlaltw%3D%3D
14. G Pinhal-Enfield M Ramanathan G Hasko SN Vogel AL Salzman GJ Boons, et al. 2003 An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors The American Journal of Pathology 163 711 721 12875990 10.1016/S0002-9440(10)63698-X 1:CAS:528:DC%2BD3sXmslSnsbc%3D (Pubitemid 36909432)
15. AH Tang GJ Brunn M Cascalho JL Platt 2007 Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions Journal of Leukocyte Biology 82 282 285 17495051 10.1189/jlb.1206752 1:CAS:528:DC%2BD2sXos12rurw%3D (Pubitemid 47230638)
16. H Wu G Chen KR Wyburn J Yin P Bertolino JM Eris, et al. 2007 TLR4 activation mediates kidney ischemia/reperfusion injury Journal of Clinical Investigation 117 2847 2859 17853945 10.1172/JCI31008 1:CAS:528: DC%2BD2sXhtFCnt73E (Pubitemid 47529615)
17. LM Kreckler TC Wan ZD Ge JA Auchampach 2006 Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor The Journal of Pharmacology and Experimental Therapeutics 317 172 180 16339914 10.1124/jpet.105.096016 1:CAS:528: DC%2BD28XjsVWmt70%3D
18. L Martin SC Pingle DM Hallam LP Rybak V Ramkumar 2006 Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2 The Journal of Pharmacology and Experimental Therapeutics 316 71 78 16188954 10.1124/jpet.105.091868 1:CAS:528:DC%2BD28Xhslekug%3D%3D (Pubitemid 41832582)
19. CD McWhinney MW Dudley TL Bowlin NP Peet L Schook M Bradshaw, et al. 1996 Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha European Journal of Pharmacology 310 209 216 8884219 10.1016/0014-2999(96)00272-5 1:CAS:528:DyaK28XlsFWlurg%3D (Pubitemid 26298264)
20. CA Salvatore SL Tilley AM Latour DS Fletcher BH Koller MA Jacobson 2000 Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells The Journal of Biological Chemistry 275 4429 4434 10660615 10.1074/jbc.275.6.4429 1:CAS:528:DC%2BD3cXht12nsr4%3D (Pubitemid 30094686)
21. BB Fredholm AP Ijzerman KA Jacobson KN Klotz J Linden 2001 International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors Pharmacological Reviews 53 527 552 11734617 1:CAS:528: DC%2BD38XltVOltQ%3D%3D (Pubitemid 33136237)
22. TL Bowlin DR Borcherding CK Edwards 3rd CD McWhinney 1997 Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo Cellular and Molecular Biology (Noisy-le-grand) 43 345 349 1:CAS:528:DyaK2sXjslyhtr0%3D
23. G Hasko C Szabo ZH Nemeth V Kvetan SM Pastores ES Vizi 1996 Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice Journal of Immunology 157 4634 4640 1:CAS:528:DyaK28XmvVWrurs%3D (Pubitemid 126449386)
24. G Hasko DG Kuhel JF Chen MA Schwarzschild EA Deitch JG Mabley, et al. 2000 Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms The FASEB Journal 14 2065 2074 10.1096/fj.99-0508com 14/13/2065 11023991 10.1096/fj.99-0508com 1:CAS:528:DC%2BD3MXhtF2rt7Y%3D
25. LM Kreckler E Gizewski TC Wan JA Auchampach 2009 Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway The Journal of Pharmacology and Experimental Therapeutics 331 1051 1061 10.1124/jpet.109.157651 19749080 10.1124/jpet.109. 157651 1:CAS:528:DC%2BD1MXhsFaqsLvI
26. LJ Murphree GW Sullivan MA Marshall J Linden 2005 Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction The Biochemical Journal 391 575 580 16022683 10.1042/BJ20050888 1:CAS:528:DC%2BD2MXhtFCqs77I (Pubitemid 41634783)
27. ND Khoa MC Montesinos AB Reiss D Delano N Awadallah BN Cronstein 2001 Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells Journal of Immunology 167 4026 4032 1:CAS:528:DC%2BD3MXntFajtbw%3D (Pubitemid 32910848)
28. ND Khoa M Postow J Danielsson BN Cronstein 2006 Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane Molecular Pharmacology 69 1311 1319 10.1124/mol.105.016857 16385076 10.1124/mol.105.016857 1:CAS:528: DC%2BD28XjtlKntLY%3D